IART Q2 2021 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$390M+50.8% YoY

Gross Profit

$239M61.2% margin

Operating Income

$52M13.3% margin

Net Income

$35M9.0% margin

EPS (Diluted)

$0.41

QoQ Revenue Growth

+8.3%

Cash Flow

Operating Cash Flow

$91M

Free Cash Flow

$85M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$2.1B

Stockholders' Equity

$1.6B

Cash & Equivalents

$397M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$390M	$259M	+50.8%
Gross Profit	$239M	$153M	+55.8%
Operating Income	$52M	$14M	+268.3%
Net Income	$35M	-$369,000	+9603.5%

Revenue Segments

Codman Specialty Surgical

$257M66%

Tissue Technologies

$133M34%

Geographic Segments

UNITED STATES

$278M71%

Europe

$48M12%

Asia Pacific

$44M11%

Rest Of World

$19M5%